# AgomAb Therapeutics NV: financial statements, quarterly

AGMB · Nasdaq · CIK 2020932 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agmb.md) · [Financials](/companies/agmb/financials.md) · [Filings](/companies/agmb/filings.md) · [Insiders](/companies/agmb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/agmb/financials.md?period=annual).

None of the standardized line items are reported.

Shares outstanding: 34,167,168 at 2025-12-31, from the cover of the [20-F filed 2026-04-23](/filings/0001104659-26-047872.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.